ACM
WST icon

ADAR1 Capital Management’s West Pharmaceutical WST Stock Holding History

ADAR1 Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$60K – 306
2024
Q3 		$60K Sell
200
-690
-78% -$211K 0.01% 207
2024
Q2 		$293K Sell
890
-610
-41% -$216K 0.06% 126
2024
Q1 		$594K Buy
+1,500
New +$555K 0.13% 76

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

ADAR1 Capital Management's WST Position: Q4 2024 in Review

ADAR1 Capital Management sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 200 shares — an estimated $60K sold.

ADAR1 Capital Management first reported a position in WST in Q1 2024 and held it in 3 quarters. The position peaked at $594K in Q1 2024. 747 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • ADAR1 Capital Management reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 200 West Pharmaceutical shares in Q4 2024, an estimated $60K.
  • ADAR1 Capital Management first reported a position in West Pharmaceutical in Q1 2024 and held it in 3 quarters.
  • ADAR1 Capital Management's West Pharmaceutical position peaked at $594K in Q1 2024.
  • 747 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on ADAR1 Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.